AN EXPERIMENTAL DERMAL SAFETY STUDY OF SCHEDULE E (1) DRUG - VISHTINDUKA AND THE ROLE OF ITS TAILA & VATARI GUGGULU IN GRIDHRASI

Ayurveda,an ancient science of life, focuses on maintaining balance for health andlongevity. It divides health principles into eight branches, one of which is AgadTantra, dealing with poisons and their treatment. Acharya Charak emphasizedthat poisons, when properly prepared, can become medicines, and conversely,even beneficial medicines can become toxic if used incorrectly. A key part ofAyurveda is understanding Tridosha—the balance of Vata, Pitta, andKapha. When these energies are in equilibrium, health prevails; imbalances leadto diseases.

Onesuch disease is Gridhrasi, similar to sciatica in modern medicine,characterized by pain, stiffness, and restricted leg movement. It arises fromimbalances in Vata, and in some cases, also Kapha. Sciatica is a commoncondition, caused by issues like poor posture, prolonged sitting, and obesity.It affects many individuals, especially those aged 30-50, and often leads topain, disability, and discomfort.

InAyurveda, treatments such as Vishtinduka Taila (derived from Strychnosnux-vomica, a poisonous plant) and Vatari Guggulu (a herbal remedy)are used for conditions like Gridhrasi. These treatments have properties likepain relief, anti-inflammatory, and nerve tonic effects. However, the toxicpotential of these treatments, especially from the use of Vishtinduka, requirescareful evaluation. Toxicity studies in animals are essential to ensure theirsafety for human use.

Thisstudy aims to evaluate the safety of Vishtinduka Taila through dermal exposurein rats and its clinical effectiveness in treating Gridhrasi. Additionally,Vatari Guggulu’s non-toxic profile has already been established. The ultimategoal is to find an effective, safe treatment for sciatica, using traditionalAyurvedic remedies.